Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Mereo BioPharma completes patient enrollment for BPS-804 Phase 2b trial in osteogenesis imperfecta British specialty biopharma company Mereo BioPharma Group has completed patient enrollment for a Phase 2b clinical trial of… bypharmanewsdailyOctober 30, 2018
